FindTrial
Sign In

A prospective, multicenter phamacoepidemiologic study for Korean rheumatoid arthritis patients who use biologic agents

BIOPSY-SF(Biologics Pharmacoepidemiologic Study-Short Form)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000262
Enrollment
1100
Registered
2011-11-08
Start date
2011-07-14
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All rheumatoid arthritis patients who start biologic agents

Exclusion criteria

Exclusion criteria: Patients who do not give written informed consent to participate in the this registry

Design outcomes

Primary

MeasureTime frame
Incidence of tuberculosis in RA patients—

Secondary

MeasureTime frame
incidence of malignancy in RA patients—

Countries

Korea, Republic of

Contacts

Public ContactYoon-Kyoung Sung

Clinical Research Center for Rheumatois Arthritis

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026